Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Stocks / Alnylam Pharmaceuticals Inc
Institutional Holders · Q2 2026

Who owns Alnylam Pharmaceuticals Inc?

ALNYCUSIP 02043QAB3
47
Institutions holding · +2.2% QoQ
$423M
Aggregate reported value · −4.9%
594,763
Shares held (SH)
Top 50
The holders

Twelve quarters of conviction

Aggregate reported value (bars) against the number of institutions holding (line).
Q3 23Q4 23Q1 24Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26

The holders

Top 5 of 47 institutions, ranked by reported value. Share change is versus the manager’s previous filing.
#ManagerSharesShare Δ QoQValue% of book
1Boussard & Gavaudan Gestion Sas24,763—$30M1.5%
2Sei Investments Co251,000+0.0%$301,7890.0%
3Bank of New York Mellon Corp215,000+0.0%$258,6560.0%
4Oppenheimer Asset Management Inc.80,000−1.2%$96,1880.0%
5Stephens Inc /Ar/24,000+0.0%$28,8560.0%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.